<DOC>
	<DOCNO>NCT01654666</DOCNO>
	<brief_summary>Remote limb ischemic preconditioning ( RIPC ) neuro-protective anti-inflammatory effect ischemia- reperfusion injury . As extent effect unknown , investigator use clinical outcome , serum biochemical marker brain magnetic resonance imaging ( MRI ) determine whether RIPC neuro-protective anti-inflammatory effect patient undergo carotid artery stenting .</brief_summary>
	<brief_title>Protective Effects Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting</brief_title>
	<detailed_description>BACKGROUND : Brain ischemia injury contribute perioperative morbidity mortality Carotid Artery Stenting . Remote ischemic preconditioning ( RIPC ) , brief period ischemia follow reperfusion , provide systemic protection prolong ischemia . Our previous study find significant protection patient receive RIPC Carotid Artery Stenting . In order investigate whether long-term RIPC Carotid Artery Stenting protect patient perioperative long-term complication , prospective randomize control trial perform current study . DESIGNING : About 189 patient eligible carotid artery stenting randomly assign 1:1:1 ratio RIPC group , sham RIPC group conventional Carotid Artery Stenting group ( control ) . Remote limb ischemic preconditioning ( RIPC ) consist five 5-min cycle bilateral arm ischemia/reperfusion , induce automate cuff-inflator place bilateral arm inflate 200 mmHg 5-min follow deflate cuff 5-min , patient RIPC group twice day least two week carotid artery stenting . Patients sham RIPC group receive sham RIPC treatment , consist five 5-min cycle bilateral arm ischemia/reperfusion , induce automate cuff-inflator place bilateral arm inflate 60 mmHg 5-min follow deflate cuff 5-min , twice day least two week carotid artery stenting . Patients control group receive conventional carotid artery stenting without RIPC sham RIPC treatment . Cerebral injury assess serum S-100B Neuron specific enolase ( NSE ) , systematic inflammation assess serum high-sensitivity C-reactive protein ( hs-CRP ) . Post-treatment infarction , symptomatic asymptomatic , detect diffusion-weighted imaging ( DWI ) clinical outcome determine cerebrovascular event , cardiac event death .</detailed_description>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>1 . Symptomatic asymptomatic carotid artery stenosis . In symptomatic patient degree stenosis 60 % ( Based NASCET Criteria ) , asymptomatic patient degree stenosis 70 % ( Based NASCET Criteria ) ; 2 . Tolerance study medication , include clopidogrel , aspirin statin ; 3 . Can cooperate complete brain MRI examination ; 4 . Has negative pregnancy test within 7 day randomization childbearing potential ; 5 . Vascular ultrasound exclude intravascular thrombosis unstable plaque blood vessel bilateral upper limb ; 6 . No hemorrhagic tendency ; 7 . Stable vital sign , normal renal hepatic function ; 8 . Informed consent . 1 . Evolving stroke ; 2 . Prior major ipsilateral stroke , likely confound study endpoint ; 3 . Severe dementia ; 4 . Hemorrhagic conversion ischemic stroke within past 60 day ; 5 . Chronic atrial fibrillation ; 6 . Myocardial infarction within previous 30 day ; 7 . Inability understand cooperate study procedure provide informed consent ; 8 . Participating device drug trial complete require protocol followup period ; 9 . Any condition hamper proper angiographic assessment make percutaneous arterial access unsafe ; 10 . High risk candidate define Carotid Revascularization Endarterectomy vs. Stenting Trial ( CREST ) ; 11 . Any vascular , extremity soft tissue orthopedic injury may contraindicate bilateral arm ischemic preconditioning ( e.g . superficial wound fracture arm ) ; 12 . Blood pressure control low 200 mmHg medication ; 13 . Peripheral blood vessel disease ( especially subclavian arterial upper limb artery stenosis occlusion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Remote ischemic preconditioning</keyword>
	<keyword>Stroke secondary prevention</keyword>
	<keyword>Carotid artery stenting</keyword>
	<keyword>Carotid stenosis</keyword>
	<keyword>Inflammation</keyword>
</DOC>